Shinko Asset Management Co., Ltd. - ISIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Shinko Asset Management Co., Ltd. ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$15,000
-28.6%
3670.0%0.00%
Q2 2015$21,000
-8.7%
3670.0%0.00%
Q1 2015$23,0003670.00%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
BB BIOTECH AG 5,729,426$364,793,00010.87%
DOWLING & YAHNKE LLC 676,323$43,061,0005.38%
WILLIAM HARRIS INVESTORS INC 229,887$14,638,0003.84%
Opus Point Partners Management, LLC 60,912$3,878,0003.25%
Nepsis Inc. 64,580$4,112,0002.48%
Private Capital Advisors, Inc. 106,320$6,769,0002.46%
PINNACLE ASSOCIATES LTD 1,889,017$120,274,0002.24%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 20,947$1,333,0001.90%
Apex Capital Management 928,654$59,127,0001.39%
Bellevue Asset Management AG 147,000$9,359,0001.31%
View complete list of ISIS PHARMACEUTICALS INC shareholders